Gabexate mesilate ameliorates the neuropathic pain in a rat model by inhibition of proinflammatory cytokines and nitric oxide pathway via suppression of nuclear factor-κB

키워드

참고문헌 (47)

1. Gao J, "Pro-resolving mediator maresin 1 ameliorates pain hypersensitivity in a rat spinal nerve ligation model of neuropathic pain", J Pain Res, 11, pp.1511~1519 (2018)
2. Oh SH, "Urinary trypsin inhibitor attenuates the development of neuropathic pain following spinal nerve ligation", Neurosci Lett, 590, pp.150~155 (2015)
3. Guindon J, "Cannabinoid CB2 receptors : a therapeutic target for the treatment of inflammatory and neuropathic pain", Br J Pharmacol, 153, pp.319~334 (2008)
4. Sacerdote P, "Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain", J Neuroimmune Pharmacol, 8, pp.202~211 (2013)
5. Austin PJ, "The neuro-immune balance in neuropathic pain : involvement of inflammatory immune cells, immune-like glial cells and cytokines", J Neuroimmunol, 229, pp.26~50 (2010)
6. Mithilesh Kumar Jha, "Glia as a Link between Neuroinflammation and Neuropathic Pain", Immune Network, 12(2), pp.41~47 (2012), 대한면역학회[DOI]
7. Moalem G, "Immune and inflammatory mechanisms in neuropathic pain", Brain Res Rev, 51, pp.240~264 (2006)
8. Zelenka M, "Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain", Pain, 116, pp.257~263 (2005)
9. Myers RR, "The role of neuroinflammation in neuropathic pain : mechanisms and therapeutic targets", Drug Discov Today, 11, pp.8~20 (2006)
10. Schäfers M, "Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1receptor has an additive effect in reducing neuropathic pain in mice", Neurosci Lett, 310, pp.113~116 (2001)
11. Sommer C, "Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy", Neurosci Lett, 270, pp.25~28 (1999)
12. 박지훈, "Effect of ulinastatin on cytokine reaction during gastrectomy", Korean Journal of Anesthesiology, 58(4), pp.334~337 (2010), 대한마취통증의학회
13. Moggia E, "Pharmacological interventions for acute pancreatitis", Cochrane Database Syst Rev, 4, pp.CD011384~ (2017)
14. 정기태, "The Effect of Urinary Trypsin Inhibitor Against Neuropathic Pain in Rat Models", The Korean Journal of Pain, 26(4), pp.356~360 (2013), 대한통증학회
15. Taoka Y, "Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats", Crit Care Med, 25, pp.874~879 (1997)
16. Shih RH, "NF-kappaB signaling pathways in neurological inflammation : a mini review", Front Mol Neurosci, 8, pp.77~ (2015)
17. Colasanti M, "Effect of gabexate mesylate(FOY), a drug for serine proteinase-mediated diseases, on the nitric oxide pathway", Biochem Biophys Res Commun, 246, pp.453~456 (1998)
18. Carrasco C, "Neuropathic pain : delving into the oxidative origin and the possible implication of transient receptor potential channels", Front Physiol, 9, pp.95~ (2018)
19. Freire MA, "Pain modulation by nitric oxide in the spinal cord", Front Neurosci, 3, pp.175~181 (2009)
20. Zimmermann M, "Ethical guidelines for investigations of experimental pain in conscious animals", Pain, 16, pp.109~110 (1983)
21. Kim SH, "An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat", Pain, 50, pp.355~363 (1992)
22. Chung JM, "Segmental spinal nerve ligation model of neuropathic pain", Methods Mol Med, 99, pp.35~45 (2004)
23. Chaplan SR, "Quantitative assessment of tactile allodynia in the rat paw", J Neurosci Methods, 53, pp.55~63 (1994)
24. Thacker MA, "Pathophysiology of peripheral neuropathic pain : immune cells and molecules", Anesth Analg, 105, pp.838~847 (2007)
25. Uçeyler N, "Cytokine regulation in animal models of neuropathic pain and in human diseases", Neurosci Lett, 437, pp.194~198 (2008)
26. Gao YJ, "JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain", J Neurosci, 29, pp.4096~4108 (2009)
27. Shamash S, "The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta", J Neurosci, 22, pp.3052~3060 (2002)
28. Leung L, "TNF-alpha and neuropathic pain--a review", J Neuroinflammation, 7, pp.27~ (2010)
29. Gui WS, "Interleukin-1β overproduction is a common cause for neuropathic pain, memory deficit, and depression following peripheral nerve injury in rodents", Mol Pain, 12, pp.1744806916646784~ (2016)
30. Li X, "Tumor necrosis factor-α of red nucleus involved in the development of neuropathic allodynia", Brain Res Bull, 77, pp.233~236 (2008)
31. Ding CP, "The red nucleus interleukin-6 participates in the maintenance of neuropathic pain induced by spared nerve injury", Neurochem Res, 41, pp.3042~3051 (2016)
32. Lu Y, "MicroRNA-146a-5p attenuates neuropathic pain via suppressing TRAF6 signaling in the spinal cord", Brain Behav Immun, 49, pp.119~129 (2015)
33. Lu Y, "TRAF6upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-α and IL-1β signaling", Pain, 155, pp.2618~2629 (2014)
34. Lin TB, "Fbxo3-dependent Fbxl2 ubiquitination mediates neuropathic allodynia through the TRAF2", TNIK, J Neurosci, pp.2015, 35[DOI]
35. Levy D, "NO pain : potential roles of nitric oxide in neuropathic pain", Pain Pract, 4, pp.11~18 (2004)
36. Liu DL, "Peroxiredoxin 1-mediated activation of TLR4", NF-κB pathway contributes to neuroinflammatory injury in intracerebral hemorrhage, 2016, pp.41, 82~89
37. Pei W, "Tizanidine exerts anti-nociceptive effects in spared nerve injury model of neuropathic pain through inhibition of TLR4", NF-κB pathway, 2018, pp.42, 3209~3219
38. Lee KM, "Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity", Eur J Neurosci, 19, pp.3375~3381 (2004)
39. Meunier A, "Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat", Mol Ther, 15, pp.687~697 (2007)
40. Brambilla R, "Inhibition of astroglial nuclear factor kap-paB reduces inflammation and improves functional recovery after spinal cord injury", J Exp Med, 202, pp.145~156 (2005)
41. Rivot JP, "Subcutaneous formalin and intraplantar carrageenan increase nitric oxide release as measured by in vivo voltammetry in the spinal cord", Eur J Pain, 6, pp.25~34 (2002)
42. Schomberg D, "Neuropathic pain : role of inflammation, immune response, and ion channel activity in central injury mechanisms", Ann Neurosci, 19, pp.125~132 (2012)
43. Gao X, "Reactive oxygen species(ROS)are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain", Pain, 131, pp.262~271 (2007)
44. Inoue T, "Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model", Brain Res, 792, pp.263~270 (1998)
45. Roche AK, "A nitric oxide synthesis inhibitor(L-NAME)reduces licking behavior and Fos-labeling in the spinal cord of rats during formalininduced inflammation", Pain, 66, pp.331~341 (1996)
46. Lee HL, "Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model", Neuroreport, 15, pp.2807~2811 (2004)
47. Röyttä M, "Spinal nerve ligation-induced neuropathy in the rat : sensory disorders and correlation between histology of the peripheral nerves", Pain, 80, pp.161~170 (1999)

관련 논문AI추천